Caniglia et al., Comparison of monitoring strategies based on CD4 cell counts in virally suppressed HIV-positive individuals
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational study. Lancet HIV Caniglia et al. on behalf of the HIV-CAUSAL Collaboration and the Centers for AIDS Research Network of Integrated Clinical Systems aimed to establish whether information […]
Lodi et al., Immediate ART in older HIV positive patients
Effect of immediate initiation of antiretroviral treatment in HIV-positive individuals aged 50 years or older. Journal of Acquired Immune Deficiency Syndromes Clinical guidelines recommend immediate initiation of combined antiretroviral therapy for all HIV-positive individuals. However, those guidelines are based on trials of relatively young participants. Lodi et al. on behalf of the HIV-CAUSAL Collaboration […]
Leitman et al., HLA-B*14:02-env-restricted CD8+ T-cells in HIV control
HLA-B*14:02-restricted env-specific CD8+ T-cell activity has highly potent antiviral efficacy associated with immune control of HIV infection. Journal of Virology Immune control of HIV infection is typically associated with effective Gag-specific CD8+ T-cell responses. To investigate further the potential role of non-Gag-specific CD8+ T-cell responses in control of HIV infection, Leitman et al. focused […]
Béguelin et al., Aumento dei trattamenti e del tasso di guarigione dell’epatite C nei partecipanti allo SHCS 2011-2015
Aumento dei trattamenti e del tasso di guarigione dell’epatite C nei partecipanti allo Studio svizzero della coorte HIV (SHCS) 2011-2015. Liver International I medicamenti anti-HCV (virus dell’epatite C), i cosiddetti agenti antivirali ad azione diretta (AAD), sono estremamente efficaci, ben tollerati e disponibili in Svizzera dal novembre 2011. Vi presentiamo i dati di uno […]
Béguelin et al., Zunahme der Behandlungen und der Heilungsraten von Hepatitis C in der SHCS zwischen 2011 – 2015
Zunahme der Behandlungen und der Heilungsraten von Hepatitis C Infektionen bei Teilnehmern der Schweizerischen HIV Kohortenstudie zwischen 2011 und 2015. Liver International Seit Ende November 2011 sind in der Schweiz hochwirksame und gut verträgliche Medikamente zur Behandlung der Hepatitis C (HCV) Infektion verfügbar. Die Autoren haben in der vorliegenden Studie in der Schweizerischen HIV Kohortenstudie […]
Béguelin et al., Augmentation des traitements et du taux de guérison l’hépatite C chez les participants SHCS entre 2011 et 2015
Augmentation des traitements et du taux de guérison des infections par le virus de l’hépatite C chez les participants à l’Etude suisse de cohorte VIH (SHCS) entre 2011 et 2015. Liver International Depuis fin novembre 2011, des médicaments anti-VHC (virus de l’hépatite C) hautement efficaces et bien tolérés sont disponibles en Suisse. Les auteurs […]
Del Amo et al., Educational level and response to antiretroviral treatment
Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe (1996-2013): a collaborative cohort study. AIDS Del Amo et al. on behalf of COHERE in Euro-Coord aimed to investigate differences by educational level in virological and immunological response to combined antiretroviral treatment (cART), as well […]
Bouteloup et al., Reference curves for CD4 response
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients. HIV Medicine Bouteloup et al. on behalf of COHERE in EuroCoord aimed to provide ‘reference curves’ for CD4 T-cell responses during the first 12 months of combination antiretroviral therapy (cART) for patients with virological suppression, according to the […]
Monge et al., Combined antiretroviral treatment in migrants in Europe
Timing of cART initiation in male and female migrants living with HIV in Western Europe: an observational cohort study (1997-2013). AIDS The Migrant Health Working Group on behalf of COHERE in EuroCoord aimed to evaluate differences in timing of combined antiretroviral treatment (cART) initiation by geographical origin in male and female HIV-positive patients in […]
Judd et al., Triple-class failure by age and perinatal HIV
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe. HIV Medicine Judd et al. on behalf of COHERE in EuroCoord aimed to determine the time to, and risk factors for, triple-class virological failure (TCVF) across age groups for children and adolescents with perinatally acquired HIV infection […]